Pfizer and BioNTech request EUA for COVID-19 vaccine in young children

Image by Marko Geber/Getty Visuals

Pfizer and BioNTech have formally requested that their COVID-19 vaccine be cleared for use amid young children.

In a tweet Thursday, Pfizer reported the businesses submitted their request for an emergency use authorization (EUA) of their vaccine to the U.S. Foods and Drug Administration. They are seeking clearance for it to be applied amid children aged five to 11 years aged.

The request for EUA will be evaluated for the duration of an future Vaccines and Relevant Organic Items Advisory Committee (VRBPAC) conference on Oct 26.

“We know from our huge knowledge with other pediatric vaccines that children are not compact adults, and we will conduct a complete evaluation of clinical trial info submitted in support of the basic safety and performance of the vaccine applied in a younger pediatric population, which may perhaps want a distinct dosage or formulation from that applied in an older pediatric population or adults,” Performing Fda Commissioner Dr. Janet Woodcock reported in a assertion.


The EUA submission arrives as no shock since the businesses reported they would seek out regulatory acceptance “as before long as attainable” previous month when they produced vaccine info amid children aged five to 11.

The info showed that a lesser dose of Pfizer and BioNTech’s vaccine elicited a related antibody reaction and had equivalent aspect outcomes as noticed in people today 16 to twenty five years of age.

As famous in Pfizer’s tweet, COVID-19 conditions amid young children are on the rise. All through the week of September thirty, 173,469 child COVID-19 conditions were documented, representing of all conditions recorded that week, in accordance to the American Academy of Pediatrics.

In the two-week period of time prior to September thirty, there was a seven% maximize in the cumulative amount of child COVID-19 conditions since the commencing of the pandemic, the AAP observed.

“With new conditions in children in the U.S. continuing to be at a higher stage, this submission is an vital move in our ongoing exertion towards #COVID19,” Pfizer reported in its tweet. “We are dedicated to functioning with the Fda with the final objective of encouraging defend children towards this major community well being menace.”

THE Bigger Trend

In August, Pfizer and BioNTech’s COVID-19 vaccine turned the to start with to acquire full acceptance from the Fda. The vaccine is now promoted as Comirnaty and is accredited for the avoidance of COVID-19 for those people 16 years aged and older.

The businesses have also gotten a EUA for a booster shot of Comirnaty amid sure populations, such as those people sixty five years of age and older, people 18 by way of 64  at higher chance of severe COVID-19 and those people aged 18 by way of 64 whose occupational publicity sites them at higher chance of major complications of COVID-19.

Moderna and Johnson & Johnson have also submitted requests to the Fda for booster shot EUAs. The VRBPAC has scheduled conferences for Oct fourteen and fifteen to discuss attainable booster shot approvals.

Twitter: @HackettMallory
E-mail the writer: [email protected]